Worth reading
61In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
17567455
SharesWording
Definitive
How definitive the wording is.This transaction
This tender offerDisclosing companyOMRON Corporation
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.
Date of board resolution18 May 2026
Execution Date / Effective DateExecution/effective date
Consideration and expenses
Type of ConsiderationCash
Tender offer price¥1,110 per common share and ¥717,600 per stock acquisition right
Minimum number of shares to be purchased11,230,300 shares
Tender offer periodTender offer period
Procedures and assumptions
Conditions Precedent to ExecutionCondition precedent to execution
Management structure after acquisitionPost-acquisition management structure
| Item | Details |
|---|---|
| Transaction name | This tender offer |
| Name of the Subject Company | Matsuya R&D Co., Ltd. |
| Type of Consideration | Cash |
| Tender offer price | ¥1,110 per common share and ¥717,600 per stock acquisition right |
| Minimum number of shares to be purchased | 11,230,300 shares |
| Tender offer period | Tender offer period |
| Number of shares acquired | Number of shares acquired |
| Voting rights ownership percentage | Before 14.64% → after 95.88% |
| Date of board resolution | 18 May 2026 |
| Execution Date / Effective Date | Execution/effective date |
| Conditions Precedent to Execution | Condition precedent to execution |
| Management structure after acquisition | Post-acquisition management structure |
Items this document does not state (20)
Counterparty nameBusiness Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceMerger ratio/share exchange ratioFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceContract DateValuation methodologyIndependent valuation institutionSpecial Committee
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This document does not explain the reasons for the transaction, stating that there have been no changes from the Notice Regarding the Commencement of the Tender Offer dated 18 May 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.